Trial intelligence / Profile preview

Ketamine Versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Erector Spinae Block in Breast Cancer Surgery

NCT04275661Phase 2Completed

Sponsor
Assiut University
Start
Aug 2020
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, triple-blind trial of ketamine and magnesium sulfate in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoints: Total morphine consumption in first 48 hours and Time to first request of analgesia at 48 hours. Started Aug 2020; status: completed.

02

Drugs

ketaminemagnesium sulfate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04275661.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04275661.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call